Getting Real About Personalized Medicine w/ Jim Wallace, CEO & Author of Precision Medicine

Send us a text

What if your medications are working against you?

Jim Wallace, former CEO of DecisionRx and Author of "Precision Medicine: AI and the Science of Personalized Healthcare," joins CareTalk to expose the massive issue of medication misfires and how pharmacogenomics can help fix it.

From his time at SpaceX to leading innovation in personalized medicine, Jim explains why your DNA holds the key to safer, more effective care—and why you might not want to wait for your doctor or insurer to catch up.

🎙️⚕️ABOUT JIM WALLACE
Strategist and executive operating at the intersection of science, technology, and health. Proven track record leading private equity–backed companies and advising investors, providers, and policymakers on the shift from volume-based to personalized care.

Author of Precision Medicine: AI and the Science of Personalized Healthcare (Wiley), a roadmap for transforming medicine through wearable tech, genomics, Big Data, and AI. The book offers a practical vision for replacing one-size-fits-all medicine with scalable, individualized healthcare.

Senior researcher at Harvard Business School, with an MBA from Harvard and a Doctor of Business Administration from the University of South Florida. Board member and frequent speaker at national healthcare forums, with a focus on bridging cutting-edge science and real-world implementation.

🎙️⚕️ABOUT CARETALK
CareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy.

GET IN TOUCH
Follow CareTalk on LinkedIn
Become a CareTalk sponsor
Guest appearance requests
Visit us on the web
Subscribe to the CareTalk Newsletter

Support the show

⚙️CareTalk: Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.